1. Home
  2. PRMB vs CORT Comparison

PRMB vs CORT Comparison

Compare PRMB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primo Brands Corporation

PRMB

Primo Brands Corporation

HOLD

Current Price

$22.70

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$95.36

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRMB
CORT
Founded
1955
1998
Country
United States
United States
Employees
12000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
PRMB
CORT
Price
$22.70
$95.36
Analyst Decision
Buy
Buy
Analyst Count
9
5
Target Price
$24.00
$96.50
AVG Volume (30 Days)
2.7M
1.1M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$761,407,000.00
Revenue This Year
$2.34
$26.08
Revenue Next Year
$3.56
$26.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.79
52 Week Low
$14.36
$28.66
52 Week High
$29.00
$97.05

Technical Indicators

Market Signals
Indicator
PRMB
CORT
Relative Strength Index (RSI) 38.60 63.30
Support Level $21.74 $76.41
Resistance Level $22.96 N/A
Average True Range (ATR) 0.75 4.17
MACD -0.25 -0.36
Stochastic Oscillator 5.21 81.02

Price Performance

Historical Comparison
PRMB
CORT

About PRMB Primo Brands Corporation

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: